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The number of options for approaching a diseased aortic
valve is probably the largest existing in the field of surgery.
The spectrum starts with transcatheter balloon angioplas-
ties, continues with surgical reconstructions and with the
prosthetic replacements of the valve (including at times
the aortic root), and ends up with prosthesis implantations
(the so-called TAVI procedure). Solely in the “replacement
store”, you’ll be offered another large array of possibilities,
ranging from a Ross procedure (which encompasses three
different techniques) to the use of homografts, or biolog-
ical (stented or non-stented) and mechanical prosthesis.
There are wide overlaps between all these methods regard-
ing their advantages or disadvantages, but it remains a fact
that two major principles continue to govern our choices:
(1) the closer we stay to a native aortic valve the better, and
(2) the younger the patient, the more decisive a slight ad-
vantage of a technique will appear over time.
The Ozaki procedure – which is a tailored replacement
of each individual valvular leaflet with treated autologous
pericardial patches – tends to exactly replicate the anatomy
of a normal aortic valve. In this regard, the challenge has
been met. What is still inferior to a native valve is the pres-
ence of non-living tissues. And this probably will be the
Achilles’ heel of the method, as it has been whenever a
patch of pericardium has been employed to replace or to
augment a leaflet. In this respect, the mid-term results of
reconstructed aortic leaflets are worth remembering. The
stability of the repair remains over 96% at 8 years if no
foreign material (always autologous pericardium) has been
used, whereas it drops to under 80% with its use [1]. The
attrition rate is directly proportional to the amount of non-
living tissue present in the leaflets.
Given the characteristics of all methods, the Ozaki proce-
dure will find its place between the repair of the valve and
its classical replacement, especially in the face of a small
annulus and, possibly, in young patients. Its major advan-
tage remains the creation of a wide opening area with a
resulting low transvalvular gradient. The longevity of the
tanned autologous pericardium might exceed that of the
well-established pericardial prostheses, but this assump-
tion remains to be proven. The haemodynamic advantage,
however, diminishes with the patients’ age and in the face
of a decent or of an enlarged aortic annulus. In this set-
ting, the surgical complexity and the longer ischaemic time
of the procedure will have to be weighed against the out-
come with some rapidly expanding prostheses (some of
them show virtually no annular area loss [2]). Finally, in
children where the growth of the heart remains an issue,
the Ross procedure will still be superior [3].
The Basel team must be commended for having success-
fully introduced the Ozaki procedure into our latitudes and
for having achieved nice results with a demanding oper-
ation [4]. Even though the procedure can provide an ex-
cellent and, in many aspects, a superior outcome for many
diseased aortic valves, it is still not equivalent to a well-
performed valve repair.
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